Drug, delivery and devices for diabetic retinopathy (3Ds in DR)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug, delivery and devices for diabetic retinopathy (3Ds in DR)

Published:2016-05-30 Issue:11 Volume:13 Page:1625-1637
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Nirmal Jayabalan¹,Radhakrishnan Krishna¹,Moreno Miguel¹,Natarajan Jayaganesh V.¹,Laude Augustinus²,Lim Tock Han²³,Venkatraman Subbu¹,Agrawal Rupesh²³

Affiliation:

1. NTU-Northwestern Institute for Nanomedicine (NTU), School of Material Science & Engineering (MSE), Nanyang Technological University, Singapore

2. National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore

3. School of Material Science & Engineering (MSE), Nanyang Technological University, Singapore, Singapore

Funder

National Healthcare Group

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2016.1188800

Reference124 articles.

1. Perspectives on diabetic retinopathy

2. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions

3. Diabetic Retinopathy and Diabetic Macular Edema

4. Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy

5. Current Treatment Approaches in Diabetic Macular Edema

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Updates on Nanocarriers for Drug Delivery in Posterior Segment Diseases with Emphasis on Diabetic Retinopathy;Current Diabetes Reviews;2023-10-17

2. Nanocarriers for ocular drug delivery: Recent advances and future opportunities;Indian Journal of Ophthalmology;2023-06

3. Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema;Pharmaceutics;2022-12-29

4. Newer therapeutic agents for retinal diseases;Expert Review of Ophthalmology;2022-01-02

5. Advanced drug delivery systems for treatment of diabetes mellitus;Drug Delivery Systems for Metabolic Disorders;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3